New perspective on cancer of the contralateral breast: a marker for assessing tamoxifen as a preventive agent
- PMID: 1832192
- DOI: 10.1093/jnci/83.18.1278
New perspective on cancer of the contralateral breast: a marker for assessing tamoxifen as a preventive agent
Comment on
-
Contralateral primary tumors in breast cancer patients in a randomized trial of adjuvant tamoxifen therapy.J Natl Cancer Inst. 1991 Sep 18;83(18):1299-306. doi: 10.1093/jnci/83.18.1299. J Natl Cancer Inst. 1991. PMID: 1886157 Clinical Trial.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
